Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Nitrofurantoin

5

XV.f Path: Diffuse alveolar damage (DAD-pattern) (see also IL)

1
Last update : 27/10/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment.
BMC pulmonary medicine 2020 Nov 26;20;313 2020 Nov 26
Downstaging of Non-Small-Cell Lung Cancer Through Identification of Reversible Drug Toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jan 10;34;e6-8 2016 Jan 10
Nitrofurantoin-induced alterations in pulmonary tissue. A report on five patients with acute or subacute reactions.
Acta pathologica et microbiologica Scandinavica. Section A, Pathology 1977 Sep;85;713-20 1977 Sep

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies